Bioasis Technologies Stock Buy Hold or Sell Recommendation

BIOAF Stock  USD 0.0001  0.00  0.00%   
Assuming the 90 days horizon and your above-average risk tolerance, our recommendation regarding biOasis Technologies is 'Strong Sell'. Macroaxis provides BiOasis Technologies buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding BIOAF positions.
  
Check out BiOasis Technologies Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
Note, we conduct extensive research on individual companies such as BiOasis and provide practical buy, sell, or hold advice based on investors' constraints. biOasis Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Execute BiOasis Technologies Buy or Sell Advice

The BiOasis recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on biOasis Technologies. Macroaxis does not own or have any residual interests in biOasis Technologies or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute BiOasis Technologies' advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell BiOasis TechnologiesBuy BiOasis Technologies
Not Rated
For the selected time horizon biOasis Technologies has a Return On Asset of -0.81, Operating Margin of (11.41) %, Current Valuation of 6 M, Shares Outstanding of 79.41 M, Shares Owned By Insiders of 2.05 % and Price To Earning of 13.82 X
We provide trade advice to complement the prevailing expert consensus on biOasis Technologies. Our dynamic recommendation engine uses a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at this particular time. To make sure BiOasis Technologies is not overpriced, please confirm all biOasis Technologies fundamentals, including its total debt, target price, and the relationship between the net income and book value per share . As biOasis Technologies appears to be a penny stock we also recommend to validate its price to sales numbers.

BiOasis Technologies Trading Alerts and Improvement Suggestions

biOasis Technologies generated a negative expected return over the last 90 days
biOasis Technologies has some characteristics of a very speculative penny stock
biOasis Technologies has a very high chance of going through financial distress in the upcoming years
biOasis Technologies has accumulated 401.76 K in total debt with debt to equity ratio (D/E) of 0.31, which is about average as compared to similar companies. biOasis Technologies has a current ratio of 0.37, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist BiOasis Technologies until it has trouble settling it off, either with new capital or with free cash flow. So, BiOasis Technologies' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like biOasis Technologies sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for BiOasis to invest in growth at high rates of return. When we think about BiOasis Technologies' use of debt, we should always consider it together with cash and equity.
The entity reported the revenue of 37.73 K. Net Loss for the year was (2.96 M) with loss before overhead, payroll, taxes, and interest of (1.15 M).
biOasis Technologies has accumulated about 764.97 K in cash with (3.64 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01, which can makes it an attractive takeover target, given it will continue generating positive cash flow.

BiOasis Technologies Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to BiOasis Technologies or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that BiOasis Technologies' price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a BiOasis pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over Dow Jones
0.00
β
Beta against Dow Jones0.00
σ
Overall volatility
0.00
Ir
Information ratio 0.00

BiOasis Technologies Volatility Alert

At this time biOasis Technologies exhibits very low volatility. biOasis Technologies appears to be a penny stock. Although biOasis Technologies may be, in fact, a solid short-term or long term investment, many penny pink sheets are speculative investment instruments that are often subject to artificial stock promotion and campaigns of hype which may lead to misinformation and misrepresentation. Please make sure you fully understand upside potential and downside risks of investing in biOasis Technologies or similar risky assets. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswing without any event/news,and sudden news releases. We also encourage traders to check biographies and work history of company President, CEO or other officers before investing in high-volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on BiOasis instrument if you perfectly time your entry and exit. However, remember that penny pink sheets that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.

BiOasis Technologies Fundamentals Vs Peers

Comparing BiOasis Technologies' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze BiOasis Technologies' direct or indirect competition across all of the common fundamentals between BiOasis Technologies and the related equities. This way, we can detect undervalued stocks with similar characteristics as BiOasis Technologies or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of BiOasis Technologies' fundamental indicators could also be used in its relative valuation, which is a method of valuing BiOasis Technologies by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare BiOasis Technologies to competition
FundamentalsBiOasis TechnologiesPeer Average
Return On Asset-0.81-0.14
Operating Margin(11.41) %(5.51) %
Current Valuation6 M16.62 B
Shares Outstanding79.41 M571.82 M
Shares Owned By Insiders2.05 %10.09 %
Price To Earning13.82 X28.72 X
Price To Book53.47 X9.51 X
Price To Sales26.52 X11.42 X
Revenue37.73 K9.43 B
Gross Profit(1.15 M)27.38 B
EBITDA(3.54 M)3.9 B
Net Income(2.96 M)570.98 M
Cash And Equivalents764.97 K2.7 B
Cash Per Share0.01 X5.01 X
Total Debt401.76 K5.32 B
Debt To Equity0.31 %48.70 %
Current Ratio0.38 X2.16 X
Book Value Per Share(0.03) X1.93 K
Cash Flow From Operations(3.64 M)971.22 M
Earnings Per Share(0.03) X3.12 X
Target Price0.58
Number Of Employees2318.84 K
Beta0.39-0.15
Market Capitalization2.13 M19.03 B
Total Asset2.27 M29.47 B
Retained Earnings(18.69 M)9.33 B
Working Capital437 K1.48 B
Current Asset874 K9.34 B
Current Liabilities437 K7.9 B
Z Score-11.58.72
Net Asset2.27 M

BiOasis Technologies Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as BiOasis . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About BiOasis Technologies Buy or Sell Advice

When is the right time to buy or sell biOasis Technologies? Buying financial instruments such as BiOasis Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having BiOasis Technologies in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Oil And Gas Thematic Idea Now

Oil And Gas
Oil And Gas Theme
Companies involved in drilling, production, and distribution of oil and gas pipelines. The Oil And Gas theme has 44 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Oil And Gas Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in BiOasis Pink Sheet

BiOasis Technologies financial ratios help investors to determine whether BiOasis Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BiOasis with respect to the benefits of owning BiOasis Technologies security.